SEARCH OUR PRODUCT CATALOG

ATXN7-ZNF385D Fusion FISH Probe

The ATXN7-ZNF385D Fusion FISH Probe is used to confirm a fusion of the ATXN7 and ZNF385D genes. The fusion of the ATXN7 and ZNF385D genes has been associated with Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
ATXN7-ZNF385D-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-RERE 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-REOR 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-REGO 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-REGR 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-REAQ 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-ORRE 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-OROR 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-ORGO 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-ORAQ 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-GORE 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-GOOR 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-GOGO 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-GOGR 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-GOAQ 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-GRRE 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-GROR 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-GRGO 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-GRGR 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-GRAQ 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-AQRE 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-AQOR 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-AQGO 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-AQGR 20 (40 μL) 200 μL
ATXN7-ZNF385D-20-AQAQ 20 (40 μL) 200 μL

ATXN7 Gene Summary

The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the 'pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. This locus has been mapped to chromosome 3, and it has been determined that the diseased allele associated with spinocerebellar ataxia-7 contains 37-306 CAG repeats (near the N-terminus), compared to 4-35 in the normal allele. The encoded protein is a component of the SPT3/TAF9/GCN5 acetyltransferase (STAGA) and TBP-free TAF-containing (TFTC) chromatin remodeling complexes, and it thus plays a role in transcriptional regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2016]

Gene Name: Ataxin 7

Chromosome: CHR3: 63850232 -63989136

Locus: 3p14.1

ZNF385D Gene Summary

The Zinc Finger Protein 385D (ZNF385D) gene is located on chr3 :21462489-21792816 at 3p24.3.

Gene Name: Zinc Finger Protein 385D

Chromosome: CHR3: 21462489 -21792816

Locus: 3p24.3

Gene Diseases

The ATXN7 ZNF385D Fusion has been associated with the following diseases:

Disease Name
Stomach Adenocarcinoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Customer Publications

There are currently no FISH related publications for this probe.